SPACs in the Healthcare Sector: Structuring Transactions, Considerations and Challenges for Companies, Investors

Course Details
- smart_display Format
On-Demand
- signal_cellular_alt Difficulty Level
- work Practice Area
Health
- event Date
Wednesday, July 21, 2021
- schedule Time
1:00 p.m. ET./10:00 a.m. PT
- timer Program Length
90 minutes
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
This CLE course will guide healthcare counsel on special purpose acquisition companies (SPACs). The panel will examine SPAC formation and structuring. The panel will discuss the benefits and considerations for both private and public companies. The panel will also discuss challenges for the parties involved and offer best practices for structuring SPAC IPOs.
Faculty

Mr. Washlick is a recognized authority on federal income tax issues involving tax-exempt organizations and the Anti-Kickback Statute and the Stark Law. His guidance is often sought as his clients assess various arrangements with physicians, such as clinical joint ventures, co-management arrangements, integrated delivery systems, business joint ventures, physician recruitment, practice acquisitions, employment arrangements, hospital/physician integration planning and exclusive provider agreements. Mr. Washlick also advises healthcare industry clients, including entrepreneurs and investment-backed entities on general corporate law and regulatory healthcare-related issues, such as the corporate practice of medicine and fee splitting laws. He has experience in structuring, negotiating and documenting a variety of complex business transactions, including mergers and acquisitions, joint operating agreements, joint ventures, clinical co-management agreements, academic and clinical affiliations, and contractual relationships among providers and with third-party payors. Mr. Washlick advises clients in the formation or acquisition of new entities, the restructuring of existing entities and the creation of alliances or other integration initiatives. Mr. Washlick speaks and writes on transaction, governance, regulatory and compliance matters, and he has been published in many healthcare and tax-related publications.

Mr. Smith has more than 25 years of experience advising international and domestic companies on global capital markets and U.S. securities law, cross-border M&A transactions, international fund formation, and Shariah finance. He advises public and private companies in M&As with significant cross-border experience, advising on transactions into and out of the U.S., Canada, Europe, the Middle East, North Africa, sub-Saharan Africa, Latin America, and China. With deep experience across a wide range of industries, including financial services, healthcare, life sciences, and oil and gas, Mr. Smith has developed a focus in the cannabis space in recent years. He is also active in the use of special-purpose acquisition companies (SPACs) by private equity firms to raise assets under management.
Description
Since the pandemic created uncertainty in the market, there has been an increase in special purpose acquisition companies (SPACs). These shell companies take companies public without going through the traditional, lengthy IPO process. SPACs offer a cheaper, quicker, and often less risky path.
Healthcare SPACs bring new opportunities to market, and SPACs are helping investors get access. SPAC IPOs offer more certainty with pricing as both companies discuss and agree upon a specific deal, unlike the pricing fluctuation in a traditional IPO. Also, as a SPAC, there is much less scrutiny and nothing to disclose. Already in 2021, there have been some big SPAC deals in the healthcare sector.
Listen as our authoritative panel of healthcare attorneys examines SPAC formation and structuring. The panel will discuss the benefits and considerations for both private and public companies. The panel will also discuss challenges for the parties involved and offer best practices for structuring SPAC IPOs.
Outline
- Recent developments of SPACs in healthcare
- Overview of SPACs and key features
- Structuring considerations and issues of concern
- Private company considerations
- Public company considerations
- Sponsor considerations
- Best practices for counsel, sponsors, and sellers
Benefits
The panel will review these and other key issues:
- What factors should be considered when determining the structure of SPACs in the healthcare industry?
- How do the incentives created under SPACs differ for the sponsor and the investors?
- What are the potential tax consequences to investors?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Related Courses

The ACA and the New Administration: CMS Proposed Rule Impacting Marketplace Eligibility and Other Notable Actions
Tuesday, April 22, 2025
1:00 p.m. ET./10:00 a.m. PT

Healthcare Speaker Programs and AKS Compliance: Regulatory Update, Lessons Learned From Recent Settlements
Tuesday, May 27, 2025
1:00 p.m. ET./10:00 a.m. PT

HIPAA and Beyond: Health Information Privacy Updates
Tuesday, May 27, 2025
1:00 p.m. ET./10:00 a.m. PT
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement